APTADEL THERAPEUTICS
Aptadel Therapeutics is a pre-clinical biomedical company focused on developing an RNA-based platform of targeted therapy delivery to treat cancer.
APTADEL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2020-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.aptadeltx.com
Total Employee:
1+
Status:
Active
Total Funding:
1.7 M EUR
Technology used in webpage:
Google Maps ReCAPTCHA Google ReCAPTCHA V3
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Genegoggle
Genegoggle is a precision medicine biotech company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Relief Therapeutics
Relief Therapeutics is a clinical stage biotechnology company.
Stemson Therapeutics
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alba Pérez Foundation
Alba Pérez Foundation investment in Seed Round - Aptadel Therapeutics
Official Site Inspections
http://www.aptadeltx.com
- Host name: 74.148.214.35.bc.googleusercontent.com
- IP address: 35.214.148.74
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Aptadel Therapeutics"
Home - Aptadel Therapeutics
Aptadel Therapeutics is a pre-clinical stage drug development biotech company exploiting RNA Aptamer technologies for the treatment of cancer. The company’s lead program is focused on Ewing Sarcoma Sarcoma, a pediatric cancer with …See details»
Aptadel Therapeutics - Crunchbase Company Profile
Aptadel Therapeutics is a pre-clinical biomedical company. Aptadel Therapeutics is a pre-clinical biomedical company focused on developing an RNA-based …See details»
Aptadel Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Aptadel Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Team - Aptadel Therapeutics
Innovation expert with >10 years of experience managing cutting-edge innovation projects.Specialized in new business development in cross-cultural environments. Solid …See details»
Aptadel Therapeutics - Company Profile - Tracxn
Oct 15, 2024 Aptadel Therapeutics - Developer of RNA-based therapeutics to treat cancer. Founded by Oscar Martínez Tirado in the year 2020. Aptadel Therapeutics has 13 competitors.See details»
Aptadel Therapeutics - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
Aptadel Therapeutics Overview | SignalHire Company Profile
Organization Website: aptadeltx.com : Social Links: Aptadel Therapeutics industries Biotech: Headquarters Location: Barcelona, ES Barcelona, ES : Aptadel Therapeutics Employees Size …See details»
Aptadel Therapeutics - Overview, News & Similar companies
Www.aptadeltx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Who is Aptadel Therapeutics. …See details»
Aptadel Therapeutics SL - Drug pipelines, Patents, Clinical trials ...
Www.aptadeltx.com. Startups | Private Company | 2020 | Spain | < 10 | www.aptadeltx.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics …See details»
Aptadel Therapeutics - LinkedIn
Aptadel Therapeutics is a preclinical-stage biotech company located in Barcelona, Spain. We are developing an RNA-based delivery platform for cancer treatment.See details»
Aptadel, the new IDIBELL’s spinoff
Jan 22, 2021 Aptadel Therapeutics is a preclinical company co-founded by IDIBELL focused on developing a new platform for targeted therapy against cancer. This platform consists of nanoparticles loaded with therapeutic agents, …See details»
Contact - Aptadel Therapeutics
[email protected]; Send us a Message. Name * Email * Subject * Comment or Message * Consent * I give consent to the processing of my personal data. Processes the personal data …See details»
Aptadel Therapeutics | EU-Startups
Aptadel Therapeutics is a European preclinical-stage biotech company based in Barcelona, Spain. It focuses on the development of cancer treatments based on Aptamer technologies.See details»
SUPPORTED BY - Aptadel Therapeutics
Project CPP2021-008515 cofunded by por MCIN/AEI /10.13039/501100011033 and European Union–Next Generation EU/PRTR. Aptadel Therapeuticsvhas been awarded with the CDTI …See details»
CataloniaBio & HealthTech
CATALONIA.HEALTH. Baldiri Reixac, 4-8, Torre D (Parc Científic de Barcelona) 08028 Barcelona. Contacte . Mapa web. Avís Legal. Política de Privacitat. Política de CookiesSee details»
Nextsource | Company Profile | Aptadel Therapeutics
Explore the company profile of Aptadel Therapeutics (aptadeltx.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Technology - Aptadel Therapeutics
Aptadel Therapeutcs technology is based in RNA-Aptamers. We use our Aptamers as a platform tool to deliver different therapeutic agents with high specificity and improved safety to treat a …See details»
The future of aptamers in cancer diagnosis, prognosis and treatment
CONTACT Adrian Gabriel Torres [email protected] Head of Research and Development, Aptadel Therapeutics, Parc Cientific de Barcelona, Baldiri Reixac 4-12, 08028, Barcelona, …See details»
Pipeline - Aptadel Therapeutics
Aptadel’s platform allows the targeting of a wide variety of cancer types. ADEL-001 is an antimetastatic drug of broad indication. ADEL-101 and ADEL-102 are targeting paediatric …See details»
News - Aptadel Therapeutics
Jan 19, 2022 Cookie Duration Description; cookielawinfo-checkbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent …See details»